Metabolic Syndrome: Myths, Assessment Tools, Novel Treatments and More
Metabolic syndrome is a cluster of conditions that increase the risk of many chronic illnesses such as heart disease, stroke, diabetes and liver disease. One-third of US adults have metabolic syndrome, including 80 per cent of those who are obese. This disease is a chronic inflammatory condition and it’s treatable. According to renowned bariatric surgeon […]
Register for Novel Tools for Managing Metabolic Syndrome
Sonic Incytes Medical Corp. is pleased to host a live educational webinar on Novel Tools for Managing Metabolic Syndrome. Metabolic syndrome is a growing public health issue affecting 1 in 3 Americans. Left untreated, it greatly increases the risk of many chronic illnesses including diabetes, heart disease, and liver disease. Join renowned bariatric surgeon and […]
Learn about The Power of 3D Liver Ultrasound for NASH Clinical Trials
Join us virtually on December 1 at 10AMPT/12PM CT/1PM ET at the 5th Annual NASH Summit 2021 to learn about The Power of 3D Liver Ultrasound for NASH Clinical Trials, featuring Dr. Stephen Harrison, Medical Director, Pinnacle Clinical Research & President, Summit Clinical Research; and George Aliphtiras, CEO, Sonic Incytes Medical Corp. Key takeaways include: […]
Register for Owning NAFLD Via Reimbursement Optimization
Sonic Incytes Medical Corp. is pleased to host a live educational webinar on Owning NAFLD Via Reimbursement Optimization. Join former payer Dr. Gary Owens and revenue cycle management expert Satish Malnaik to discover how providers and payers can work together to address the emerging fatty liver disease epidemic, resulting in better patient outcomes with improved […]
VelacurTM Data Presented at 2021 AASLD The Liver Meeting
Sonic Incytes Medical Corp. is pleased to announce that data from its sponsored clinical study of VelacurTM – the first handheld 3D liver health assessment solution – will be presented during the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting®, hosted virtually November 12-15, 2021.
Sonic Incytes Showcases VelacurTM at ACG 2021
In recognition of Liver Awareness Month this October, Sonic Incytes Medical Corp. is pleased to showcase VelacurTM, the first handheld 3D liver health assessment solution, at the American College of Gastroenterology (ACG) Annual Scientific Meeting, Oct 22-27.
Join Sonic Incytes at ACG 2021
You’re invited! Join Sonic Incytes at ACG 2021. VelacurTM, the first handheld 3D liver health assessment solution, is coming to ACG 2021. If you care for patients with chronic liver disease or are interested in building your practice, we invite you to connect with us at the ACG 2021 Annual Scientific Meeting in Las Vegas. […]
Discover VelacurTM at the Annual National Liver Conference
If you practice in the field of liver disease, visit our booth at the 16th Annual National Liver Conference to learn more about VelacurTM, the first handheld 3D liver health assessment solution. Hosted October 1, 2021, this conference is intended for physicians and other health care professionals engaged in the care of patients with liver […]
Discover How You Can Grow Your Practice with VelacurTM at TSGE 2021
VelacurTM, the first handheld 3D liver health assessment solution, is coming to the 2021 Annual TSGE Conference, September 24 to 26! If you care for patients with chronic liver disease (including fatty liver disease) or are interested in building your practice, visit our booth for a live VelacurTM demo and to connect with our team. […]
Visit VelacurTM at 2021 Annual GHAPP Conference
If you specialize in the management of patients with chronic liver disease, visit our booth at the 2021 Annual GHAPP Conference to learn more about VelacurTM, the first handheld 3D liver health assessment solution. Hosted September 9-11, the GHAPP Conference is the only conference specifically designed by and for advanced practice providers (APPs) to review […]
